Baiardi et al.142 found that plasma GFAP, measured using the Simoa SR-X platform, could differentiate Alzheimer’s disease from frontotemporal dementia and supranuclear palsy with respective receiver operating characteristic (ROC) curve AUCs of 0.82 and 0.77, respectively. This evidence concerns the gene GFAP and frontotemporal dementia.